4 terminated. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Terminated 4 |
Follow Pemphigus: new trials by email Literature Review of Pemphigus trials Research Report on Pemphigus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus) efgartigimod PH20 SC, prednisone - Pemphigus Vulgaris, Pemphigus Foliaceus | Phase 3 | Terminated | argenx | 183 | 2021-07-15 | 2025-03-30 |
| A Study of PRN1008 in Patients With Pemphigus Rilzabrutinib, Placebo - Pemphigus | Phase 3 | Terminated | Principia Biopharma, a Sanofi Company | 131 | 2019-01-08 | 2023-08-02 |
| Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris Ofatumumab, Acetaminophen/paracetamol, Antihistamine (cetirizine or equivalent) - Pemphigus | Phase 3 | Terminated | GlaxoSmithKline | 1 | 2015-12-23 | 2017-06-14 |
| Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris Ofatumumab, Placebo - Pemphigus Vulgaris | Phase 3 | Terminated | Novartis Pharmaceuticals | 35 | 2013-08-13 | 2019-06-06 |
Autoimmune Diseases (1) · Rare Diseases (1)
Immune System Diseases (4) · Skin Diseases (4) · Skin Diseases, Vesiculobullous (4) · Skin and Connective Tissue Diseases (4) · Autoimmune Diseases (3) · Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Prednisone (2) · ofatumumab (2) · Acetaminophen (1) · Cetirizine (1) · Histamine Antagonists (1) · Prednisolone (1)
GlaxoSmithKline (1) · Novartis Pharmaceuticals (1) · Principia Biopharma, a Sanofi Company (1) · argenx (1)
United States (4) · Australia (3) · Greece (3) · Israel (3) · Italy (3) · Poland (3) · Bulgaria (2) · France (2) · Germany (2) · Japan (2) · Romania (2) · Serbia (2) · Spain (2) · Turkey (Türkiye) (2) · Ukraine (2)
2018 (1)